PHARMACEUTICAL COMPOSITIONS FOR LOWERING INTRAOCULAR PRESSURE CONTAINING 4-(2-(ISOPROPYLAMINO)-ETHYL)PYROCATECHOL OR 3',4'-DIHYDROXY-2-(ISOPROPYLAMINO) ACETOPHENONE

摘要

Topical administration of 4-[2-(isopropylamino)ethyl]pyrocatechol to the mammalian eye reduces intraocular pressure without side effects generally associated with adrenergic activation such as tachycardia, mydriasis, hypertension and hypotension.